Clinical Trial Update: Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the dose proportionality of the Dilatrend Suspended-Release Capsule. The study in chronic stable angina is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Angina

Drugs mentioned

• Dilatrend Suspended-Release Capsule

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Chronic Stable Angina | Phase 1 | Status: COMPLETED